High levels of CD3+ TIL were not associated with patient age, tumor size, or nodal status, but were associated with Her2-negative (P = 0.0183) and PR-negative (P = 0.0137) status, and strongly associated with high tumor grade (P < 0.0001; Table 4). This evidence concerns the gene PGR and neoplasm.